We recently published an article titled Why These 10 Dividend Stocks Are Declining? In this article, we are going to take a ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.